Status:
COMPLETED
International Study of Inflammation in COVID-19
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Rush University
Copenhagen University Hospital, Hvidovre
Conditions:
Covid19
Outcome, Fatal
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective multi-center observational study which purpose is to evaluate the ability of blood-based inflammatory markers to risk-stratify patients hospitalized for Covid-19. Blood-based bio...
Detailed Description
All consecutive patients hospitalized specifically for Covid-19 at the University of Michigan in Ann Arbor from February 1st, 2020 to date are included. Other participating centers will enroll patient...
Eligibility Criteria
Inclusion
- Positive SARS-CoV-2 test result
- Covid-19 as the primary reason for hospitalization
Exclusion
- Hospitalized primarily for non-Covid-19 reasons
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
4463 Patients enrolled
Trial Details
Trial ID
NCT04818866
Start Date
February 1 2020
End Date
December 1 2022
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109